Zacks Investment Research on MSN
CHMP backs higher-dose Wegovy as Novo Nordisk seeks 2026 EU approval
Novo Nordisk NVO announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) ...
Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly.
Below, Pasquariello breaks down some of the benefits you can realistically expect from a supplement like Daily Dose, her ...
RC Test Fight on MSN
HoryzonHD V3 FPV camera: Build, image quality, and performance
Explore the HoryzonHD V3 FPV camera in this detailed review, covering build quality, image performance, and flight testing.
Discover the most effective ways to boost your vitamin D levels and prevent vitamin D deficiency, including safe sun exposure ...
Novo Nordisk is seeking FDA approval for a 7.2 mg dose of Wegovy, nearly three times the current maximum dose. The application is under expedited FDA review, with a decision expected within one to two ...
Novo Nordisk NOVO.B-1.06%decrease; red down pointing triangle filed for U.S. approval of a higher dose of its Wegovy weight-loss injection, with a decision expected within a month or two. The Danish ...
Through the FDA’s priority voucher program, Novo Nordisk said Nov. 26 it has filed an application seeking approval of its Wegovy 7.2 milligram injection. Wegovy (semaglutide) is currently approved in ...
In a new study, heart attack survivors who received a high, personalized dose of daily vitamin D had a 52 percent lower risk of a repeat heart attack. The results suggest specific vitamin D dosing, ...
At the ObesityWeek, Novo Nordisk A/S (NYSE:NVO) presented new findings from the STEP UP phase 3b trial. The Novo Nordisk STEP UP phase 3b trial investigated the efficacy and safety of a higher, 7.2 mg ...
Please provide your email address to receive an email when new articles are posted on . Guselkumab 200 mg every 4 weeks was more beneficial in patients with high disease activity and severity than 100 ...
In a pooled analysis, the high-dose inactivated influenza vaccine provided superior protection compared with the standard-dose vaccine against hospitalisations for influenza or pneumonia; it also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results